Poly(adenosine diphosphate-ribose) polymerase 1 expression in malignant melanomas from photoexposed areas of the head and neck region.

PubWeight™: 1.13‹?› | Rank: Top 10%

🔗 View Article (PMID 16084940)

Published in Hum Pathol on July 01, 2005

Authors

Stefania Staibano1, Stefano Pepe, Lorenzo Lo Muzio, Pasquale Somma, Massimo Mascolo, Giuseppe Argenziano, Massimiliano Scalvenzi, Gaetano Salvatore, Gabriella Fabbrocini, Guido Molea, Angelo Raffaele Bianco, Chiara Carlomagno, Gaetano De Rosa

Author Affiliations

1: Pathology Section, Department of Biomorphological and Functional Sciences, University Federico II of Naples, 80127 Naples, Italy. amando.tedeschi@virgilio.it

Articles citing this

Phase I study of the poly(ADP-ribose) polymerase inhibitor, AG014699, in combination with temozolomide in patients with advanced solid tumors. Clin Cancer Res (2008) 2.56

Genetic factors associated with naevus count and dermoscopic patterns: preliminary results from the Study of Nevi in Children (SONIC). Br J Dermatol (2015) 1.47

Tissue biomarkers for prognosis in cutaneous melanoma: a systematic review and meta-analysis. J Natl Cancer Inst (2009) 1.44

Biomarker based PET Imaging of Diffuse Intrinsic Pontine Glioma in Mouse Models. Cancer Res (2017) 1.42

PARPi-FL--a fluorescent PARP1 inhibitor for glioblastoma imaging. Neoplasia (2014) 0.93

Overexpression of Chromatin Assembly Factor-1/p60 helps to predict the prognosis of melanoma patients. BMC Cancer (2010) 0.90

Poly(ADP-ribose) polymerase-1 inhibition: preclinical and clinical development of synthetic lethality. Mol Med (2011) 0.90

Association between PARP-1 V762A polymorphism and cancer susceptibility: a meta-analysis. Genet Epidemiol (2011) 0.85

Detection and delineation of oral cancer with a PARP1 targeted optical imaging agent. Sci Rep (2016) 0.85

Inherited variation in the PARP1 gene and survival from melanoma. Int J Cancer (2014) 0.85

Non-invasive PET Imaging of PARP1 Expression in Glioblastoma Models. Mol Imaging Biol (2016) 0.83

Radioiodinated PARP1 tracers for glioblastoma imaging. EJNMMI Res (2015) 0.81

Tumor suppressive effect of PARP1 and FOXO3A in gastric cancers and its clinical implications. Oncotarget (2015) 0.81

Involvement of PARP-1 Val762Ala polymorphism in the onset of cervical cancer in caucasian women. Mol Diagn Ther (2013) 0.79

Trial watch - inhibiting PARP enzymes for anticancer therapy. Mol Cell Oncol (2015) 0.79

Overexpression of chromatin assembly factor-1 p60, poly(ADP-ribose) polymerase 1 and nestin predicts metastasizing behaviour of oral cancer. Histopathology (2012) 0.79

Imaging the DNA damage response with PET and SPECT. Eur J Nucl Med Mol Imaging (2017) 0.78

Protein signatures correspond to survival outcomes of AJCC stage III melanoma patients. Pigment Cell Melanoma Res (2014) 0.77

Expression of DNA Damage Response Molecules PARP1, γH2AX, BRCA1, and BRCA2 Predicts Poor Survival of Breast Carcinoma Patients. Transl Oncol (2015) 0.77

Optical Imaging of PARP1 in Response to Radiation in Oral Squamous Cell Carcinoma. PLoS One (2016) 0.75

Individual and Combined Expression of DNA Damage Response Molecules PARP1, γH2AX, BRCA1, and BRCA2 Predict Shorter Survival of Soft Tissue Sarcoma Patients. PLoS One (2016) 0.75

High PARP-1 expression is associated with tumor invasion and poor prognosis in gastric cancer. Oncol Lett (2016) 0.75

Articles by these authors

Initial therapy with FOLFOXIRI and bevacizumab for metastatic colorectal cancer. N Engl J Med (2014) 4.81

Trastuzumab-associated cardiac adverse effects in the herceptin adjuvant trial. J Clin Oncol (2007) 4.19

Dermoscopy of pigmented skin lesions: results of a consensus meeting via the Internet. J Am Acad Dermatol (2003) 4.15

Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials. J Clin Oncol (2008) 3.21

The multiple sulfatase deficiency gene encodes an essential and limiting factor for the activity of sulfatases. Cell (2003) 2.71

A meta-analysis on the interaction between HER-2 expression and response to endocrine treatment in advanced breast cancer. Clin Cancer Res (2005) 2.60

Deletion of the p66Shc longevity gene reduces systemic and tissue oxidative stress, vascular cell apoptosis, and early atherogenesis in mice fed a high-fat diet. Proc Natl Acad Sci U S A (2003) 2.39

Dermatoscopy of basal cell carcinoma: morphologic variability of global and local features and accuracy of diagnosis. J Am Acad Dermatol (2009) 2.26

Melanoma simulating seborrheic keratosis: a major dermoscopy pitfall. Arch Dermatol (2003) 2.24

Expression of epidermal growth factor receptor correlates with disease relapse and progression to androgen-independence in human prostate cancer. Clin Cancer Res (2002) 2.01

Dermoscopy in general dermatology. Dermatology (2006) 1.92

Efficacy of tamoxifen and radiotherapy for prevention and treatment of gynaecomastia and breast pain caused by bicalutamide in prostate cancer: a randomised controlled trial. Lancet Oncol (2005) 1.84

Periodic activation of Wnt/beta-catenin signaling enhances somatic cell reprogramming mediated by cell fusion. Cell Stem Cell (2008) 1.78

Three-point checklist of dermoscopy. A new screening method for early detection of melanoma. Dermatology (2004) 1.74

Solid-pseudopapillary tumor of the pancreas: a neoplasm with distinct and highly characteristic cytological features. Diagn Cytopathol (2002) 1.73

Differential role of CD133 and CXCR4 in renal cell carcinoma. Cell Cycle (2010) 1.73

Entodermoscopy: a new tool for diagnosing skin infections and infestations. Dermatology (2008) 1.67

Dermatologists' accuracy in early diagnosis of melanoma of the nail matrix. Arch Dermatol (2010) 1.64

Dermoscopy of pigmented lesions of the mucosa and the mucocutaneous junction: results of a multicenter study by the International Dermoscopy Society (IDS). Arch Dermatol (2011) 1.63

EGFR mutations detected on cytology samples by a centralized laboratory reliably predict response to gefitinib in non-small cell lung carcinoma patients. Cancer Cytopathol (2013) 1.62

Patterns of detection of superficial spreading and nodular-type melanoma: a multicenter Italian study. Dermatol Surg (2004) 1.57

How to diagnose nonpigmented skin tumors: a review of vascular structures seen with dermoscopy: part I. Melanocytic skin tumors. J Am Acad Dermatol (2010) 1.56

Immune activation and chronic inflammation as the cause of malignancy in oral lichen planus: is there any evidence ? Oral Oncol (2004) 1.53

Time required for a complete skin examination with and without dermoscopy: a prospective, randomized multicenter study. Arch Dermatol (2008) 1.53

Dermoscopic evaluation of amelanotic and hypomelanotic melanoma. Arch Dermatol (2008) 1.51

Morphologic changes of a pigmented Spitz nevus assessed by dermoscopy. J Am Acad Dermatol (2002) 1.50

Angiosarcoma of the head and neck with intra-oral presentation. A clinico-pathological study of four cases. Oral Oncol (2002) 1.47

Dermoscopy of eccrine poroma. Dermatology (2007) 1.46

BRAF is a therapeutic target in aggressive thyroid carcinoma. Clin Cancer Res (2006) 1.43

Weekly docetaxel and vinorelbine (VIN-DOX) as first line treatment in patients with hormone refractory prostate cancer. Eur Urol (2004) 1.43

Enhancement of antitumor activity of ionizing radiation by combined treatment with the selective epidermal growth factor receptor-tyrosine kinase inhibitor ZD1839 (Iressa). Clin Cancer Res (2002) 1.43

Quantitative assessment of tumour extraction from dermoscopy images and evaluation of computer-based extraction methods for an automatic melanoma diagnostic system. Melanoma Res (2006) 1.42

cAMP and Pyk2 interact to regulate prostate cell proliferation and function. Cancer Biol Ther (2009) 1.42

Jumping into the future using teledermoscopy. Skinmed (2003) 1.41

Value of dermoscopy for the differential diagnosis of Wolf's post herpetic isotopic response. Australas J Dermatol (2014) 1.39

Dermoscopy and confocal microscopy of nested melanoma of the elderly: recognizing a newly defined entity. JAMA Dermatol (2013) 1.39

Molecular and functional analysis of SUMF1 mutations in multiple sulfatase deficiency. Hum Mutat (2004) 1.36

The spectrum of Spitz nevi: a clinicopathologic study of 83 cases. Arch Dermatol (2005) 1.36

IKK{gamma} protein is a target of BAG3 regulatory activity in human tumor growth. Proc Natl Acad Sci U S A (2010) 1.36

Dermoscopy in general dermatology. Dermatol Clin (2013) 1.36

Frequency of dermoscopic nevus subtypes by age and body site: a cross-sectional study. Arch Dermatol (2011) 1.34

Oral manifestations of celiac disease. J Clin Gastroenterol (2008) 1.34

Histological alterations in cavernous tissue after radical prostatectomy. J Urol (2005) 1.33

Dermatoscopy of facial actinic keratosis, intraepidermal carcinoma, and invasive squamous cell carcinoma: a progression model. J Am Acad Dermatol (2011) 1.32

The many faces of blue nevus: a clinicopathologic study. J Cutan Pathol (2007) 1.31

A specific miRNA signature correlates with complete pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys (2011) 1.30

The dermatologist's stethoscope-traditional and new applications of dermoscopy. Dermatol Pract Concept (2013) 1.30

Dermoscopic patterns of purpuric lesions. Arch Dermatol (2010) 1.27

Dermatologist detection and skin self-examination are associated with thinner melanomas: results from a survey of the Italian Multidisciplinary Group on Melanoma. Arch Dermatol (2003) 1.27

How to diagnose nonpigmented skin tumors: a review of vascular structures seen with dermoscopy: part II. Nonmelanocytic skin tumors. J Am Acad Dermatol (2010) 1.26

Somatostatin receptor type 2A immunohistochemistry in neuroendocrine tumors: a proposal of scoring system correlated with somatostatin receptor scintigraphy. Mod Pathol (2007) 1.25

Dermoscopy of cutaneous sarcoidosis. Dermatology (2010) 1.24

Dermoscopy for the diagnosis of porokeratosis. J Eur Acad Dermatol Venereol (2004) 1.22

Critical role of both p27KIP1 and p21CIP1/WAF1 in the antiproliferative effect of ZD1839 ('Iressa'), an epidermal growth factor receptor tyrosine kinase inhibitor, in head and neck squamous carcinoma cells. J Cell Physiol (2003) 1.22

Correction of Hunter syndrome in the MPSII mouse model by AAV2/8-mediated gene delivery. Hum Mol Genet (2006) 1.21

The multiform and variable patterns of onset of orofacial granulomatosis. J Oral Pathol Med (2003) 1.20

Human papillomavirus: its identity and controversial role in oral oncogenesis, premalignant and malignant lesions (review). Int J Oncol (2007) 1.20

Dermoscopy of uncommon skin tumours. Australas J Dermatol (2013) 1.20

Akt activation correlates with adverse outcome in tongue cancer. Cancer (2005) 1.20

Automatic detection of blue-white veil and related structures in dermoscopy images. Comput Med Imaging Graph (2008) 1.20

Bevacizumab-related arterial hypertension as a predictive marker in metastatic colorectal cancer patients. Cancer Chemother Pharmacol (2011) 1.18

Melanomas that failed dermoscopic detection: a combined clinicodermoscopic approach for not missing melanoma. Dermatol Surg (2007) 1.17

Evaluation of a combined triple method to detect causative HPV in oral and oropharyngeal squamous cell carcinomas: p16 Immunohistochemistry, Consensus PCR HPV-DNA, and In Situ Hybridization. Infect Agent Cancer (2012) 1.17

Versatility of the posterior auricular flap in partial ear reconstruction. Plast Reconstr Surg (2010) 1.17

Osteoblastoma of the mandible: clinicopathologic study of four cases and literature review. Head Neck (2005) 1.17

In vivo characterisation of superficial colorectal neoplastic lesions with high-resolution probe-based confocal laser endomicroscopy in combination with video-mosaicing: a feasibility study to enhance routine endoscopy. Dig Liver Dis (2010) 1.16

Bisphosphonate-associated jawbone osteonecrosis: a correlation between imaging techniques and histopathology. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2008) 1.15

Accuracy in melanoma detection: a 10-year multicenter survey. J Am Acad Dermatol (2011) 1.15

Dermoscopy of squamous cell carcinoma and keratoacanthoma. Arch Dermatol (2012) 1.14

Prognostic significance of multidrug-resistance protein (MDR-1) in renal clear cell carcinomas: a five year follow-up analysis. BMC Cancer (2006) 1.13

Aurora B expression directly correlates with prostate cancer malignancy and influence prostate cell proliferation. Prostate (2006) 1.12

The "ugly duckling" sign: agreement between observers. Arch Dermatol (2008) 1.11

Genetic mutations in the treatment of anaplastic thyroid cancer: a systematic review. BMC Surg (2013) 1.10

Oral mucosal diseases: mucous membrane pemphigoid. Br J Oral Maxillofac Surg (2007) 1.10

Dermoscopic changes in acral melanocytic nevi during digital follow-up. Arch Dermatol (2007) 1.10

The influence of clinical information in the histopathologic diagnosis of melanocytic skin neoplasms. PLoS One (2009) 1.09

Dermoscopy patterns of fibroepithelioma of pinkus. Arch Dermatol (2006) 1.09

Overexpression of the cytokine osteopontin identifies aggressive laryngeal squamous cell carcinomas and enhances carcinoma cell proliferation and invasiveness. Clin Cancer Res (2005) 1.09

Long-term combined beneficial effects of physical training and metabolic treatment on atherosclerosis in hypercholesterolemic mice. Proc Natl Acad Sci U S A (2004) 1.08

Beneficial effects of pomegranate juice on oxidation-sensitive genes and endothelial nitric oxide synthase activity at sites of perturbed shear stress. Proc Natl Acad Sci U S A (2005) 1.07

Diagnostic pathways and clinical significance of desquamative gingivitis. J Periodontol (2008) 1.07

Expression of COX-2, mPGE-synthase1, MDR-1 (P-gp), and Bcl-xL: a molecular pathway of H pylori-related gastric carcinogenesis. J Pathol (2004) 1.06

Dermoscopy subpatterns of inflammatory skin disorders. Arch Dermatol (2006) 1.06

Using dermoscopic criteria and patient-related factors for the management of pigmented melanocytic nevi. Arch Dermatol (2009) 1.05

The dermoscopical and histopathological patterns of nevi correlate with the frequency of BRAF mutations. J Invest Dermatol (2010) 1.04

Twenty-year results of the Naples GUN randomized trial: predictive factors of adjuvant tamoxifen efficacy in early breast cancer. Clin Cancer Res (2003) 1.04